Frontiers Case report: Short-term eculizumab use in atypical HUS

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome - ScienceDirect

PDF) Anti-factor H antibody and its role in atypical hemolytic uremic syndrome

PDF) Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Frontiers Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation

PDF) Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature

Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach.

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

PDF) Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era